Table 4 Mean ± SD of redox status parameters in testicular tissues of the different studied groups.

Treatments	MDA (nmol/mg)	Total GSH (µmol/mg)	Oxidized GSSG Conc. (nmol/mg)	Reduced GSH Conc. (nmol/mg)	GSH/GSSG
Control group	3.03 ± 0.23^b	5.62 ± 0.49^a	0.30 ± 0.02^c	5.01 ± 0.48^a	16.53 ± 1.08^a
RP10 group	3.06 ± 0.38^b	5.92 ± 0.44^a	0.33 ± 0.02^cd	5.26 ± 0.44^a	15.85 ± 1.05^a
RP20 group	3.17 ± 0.23^b	6.05 ± 0.45^a	0.34 ± 0.02^cd	5.37 ± 0.40^a	15.90 ± 1.18^a
RP40 group	4.52 ± 2.28^b	5.48 ± 1.26^a	0.35 ± 0.02^c	5.43 ± 0.39^a	12.38 ± 5.65^ab
HANPs group	7.15 ± 1.39^a	3.95 ± 0.59^b	0.65 ± 0.04^d	2.28 ± 0.34^c	5.22 ± 2.59^c
RP10 + HANPs group	4.86 ± 0.57^b	5.00 ± 0.35^ab	0.46 ± 0.04^d	3.92 ± 0.36^b	9.23 ± 1.46^bc
RP20 + HANPs group	4.18 ± 0.28^b	5.09 ± 0.32^ab	0.43 ± 0.02^dc	4.26 ± 0.34^b	9.92 ± 1.12^bc
RP40 + HANPs group	4.03 ± 0.16^b	5.22 ± 0.34^ab	0.40 ± 0.03^c	4.36 ± 0.28^b	11.36 ± 1.39^ab

Quick links

Search